[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582870":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":16,"armGroups":13,"interventions":13,"overallOfficials":13,"centralContacts":17,"locations":23,"responsibleParty":46,"collaborators":13,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":13,"enrollmentInfo":58,"targetDuration":13,"studyType":61,"phases":13,"briefSummary":62,"conditions":63,"keywords":13,"overallStatus":26,"whyStopped":13,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"IRCCS San Raffaele","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"accuracy of multiparametric preoperative MRI","Detection of \"Unfavourable outcome\" is defined as the presence of at least one of the following pathological characteristics:\n\n* High grade tumor (G3 or G4)\n* Not-organ confined disease (pT3 and or pT4 and\u002For LNI)\n* Sarcomatoid features","At final pathological assessment , at least 1 month after surgery",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":6,"timePerspective":15,"maskingInfo":13},"PROSPECTIVE","subjects with a renal tumor up to 4 cm and candidates for surgery",[18],{"name":19,"role":20,"phone":21,"phoneExt":13,"email":22},"Umberto Capitanio","CONTACT","3492503788","caitanio.umberto@hsr.it",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"IRCCS Ospedale San Raffaele","RECRUITING","Milan","Italia","20132","Italy","IT",{"type":33,"coordinates":34},"Point",[35,36],12.59836,42.78235,{"lat":36,"lon":35},[39,42],{"name":19,"role":20,"phone":40,"phoneExt":13,"email":41},"+39 3492503788","capitanio.umberto@hsr.it",{"name":43,"role":20,"phone":44,"phoneExt":13,"email":45},"Sabrina Bettini","+39 0226436268","bettini.sabrina@hsr.it",{"type":47,"investigatorFullName":19,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"PRINCIPAL_INVESTIGATOR","Group Leader Renal Cancer Lab","100582870","targeted-decision-making-in-renal-cell-carcinoma-relying-on-a-radiogenomics-translational-platform-100582870",false,"NCT06868927","Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform","TARGET-RCC","Inclusion Criteria:\n\n* Presence of a renal mass up to 4 cm\n* Adult \\> 18 years\n* Candidate to renal surgery\n* Informed consent signed\n\nExclusion Criteria:\n\n* Contraindication for MRI","ALL","18 Years",{"count":59,"type":60},50,"ESTIMATED","OBSERVATIONAL","This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy.",[64],"Renal Tumors","2026-03-16",{"date":67,"type":68},"2026-03-17","ACTUAL",{"date":70,"type":68},"2025-09-26",{"date":72,"type":60},"2029-12-31",{"name":5,"class":6},1]